Three months after President Donald Trump announced his blueprint to bring down drug prices, administration officials have begun putting some teeth behind the rhetoric. Many details have yet to be announced. But experts who pay close attention to federal drug policy and Medicare rules say the administration is preparing to incrementally roll out a multipronged plan that tasks the Centers for Medicare and Medicaid Services (CMS) and the Food and Drug Administration with promoting competition, attacking the complicated drug rebate system and introducing tactics to lower what the government pays for drugs. Broadly, the strategy falls under a handful of steps: 1. Attacking the Rebates: 2. Bringing More Negotiation to Medicare: 3. Paying for Value: 4. Tackling Foreign Drug Costs: 5. Increasing Competition. (Sarah Jane Tribble, Kaiser Health News)
